Company: HFFG
Filing Date: 2025-09-25
Form Type: 8-K
Source: 0001680873-25-000060
Chunk: 0

Company: HF Foods Group Inc.
Filing Date: 2025-09-25
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement

On September 25, 2025, HF Foods Group, Inc. (the “ Company”) entered into a Sales Agreement (the “ Sales Agreement”) with D. A. Davidson & Co. and Roth Capital Partners, LLC (the “ Sales Agents”), pursuant to which the Company may sell, from time to time, at its option, shares (the “ Shares”) of the Company’s common stock through or to the Sales Agents. The issuance and sale, if any, of shares of the Company's common stock under the Sales Agreement will be pursuant to the Company's registration statement on Form S-3 (File No. 333-281918), which became effective on September 17, 2024, and the related prospectus supplement dated September 25, 2025 (the "Prospectus Supplement"), in each case filed with the U. S. Securities and Exchange Commission (the "SEC"). In accordance with the terms of the Sales Agreement, under the Prospectus Supplement, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $100 million from time to time through the Sales Agents. The Company intends to use the proceeds from any sales for general corporate purposes which may include, among other things, funding capital expenditures, paying for possible acquisitions or the expansion of our business, and general working capital purposes.

The sale, if any, of shares of the Company's common stock under the Sales Agreement will be made by any method permitted that is deemed to be an "at-the-market" equity offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “ Securities Act”), including sales made directly on the Nasdaq Capital Market or any other trading market for the Company's common stock. Subject to the terms and conditions of the Sales Agreement, the Sales Agents will use commercially reasonable efforts to sell the shares of the Company's common stock from time to time, based upon the Company's instructions.

The compensation payable to the Sales Agents shall be up to 3.0% of the gross sales price of the shares sold through or to the Sales Agents pursuant to the Sales Agreement. In addition, the Company will reimburse the Sales Agents for certain expenses incurred in connection with the Sales Agreement, and the Company has agreed in the Sales Agreement to provide indemnification and contribution to the Sales Agents against certain liabilities, including liabilities under the Securities Act.

The Company is